Fig. 2From: The efficacy of tofacitinib combined with bDMARDs in the treatment of ankylosing spondylitis patients with inadequate response to bDMARDs: a retrospective studyLine Chart of BASDAI changes at 0 and 12 weeks. BASDAI: Bath Ankylosing Spondylitis Disease Activity IndexBack to article page